262 related articles for article (PubMed ID: 12544881)
1. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults.
Vats A; Shapiro R; Singh Randhawa P; Scantlebury V; Tuzuner A; Saxena M; Moritz ML; Beattie TJ; Gonwa T; Green MD; Ellis D
Transplantation; 2003 Jan; 75(1):105-12. PubMed ID: 12544881
[TBL] [Abstract][Full Text] [Related]
2. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.
Araya CE; Lew JF; Fennell RS; Neiberger RE; Dharnidharka VR
Pediatr Transplant; 2006 Feb; 10(1):32-7. PubMed ID: 16499584
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory BK virus-associated nephropathy with cidofovir.
Kadambi PV; Josephson MA; Williams J; Corey L; Jerome KR; Meehan SM; Limaye AP
Am J Transplant; 2003 Feb; 3(2):186-91. PubMed ID: 12614296
[TBL] [Abstract][Full Text] [Related]
4. Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients.
Lim WH; Mathew TH; Cooper JE; Bowden S; Russ GR
Nephrology (Carlton); 2003 Dec; 8(6):318-23. PubMed ID: 15012704
[TBL] [Abstract][Full Text] [Related]
5. Observations on the use of cidofovir for BK virus infection in renal transplantation.
Kuten SA; Patel SJ; Knight RJ; Gaber LW; DeVos JM; Gaber AO
Transpl Infect Dis; 2014 Dec; 16(6):975-83. PubMed ID: 25412701
[TBL] [Abstract][Full Text] [Related]
6. [BK virus infections in pediatric kidney transplant recipients].
Mutlu D; Sağlık I; Koyun M; Comak E; Mutlu E; Uslu Gökçeoğlu A; Cağla Doğan S; Dinçkan A; Akbaş SH; Akkaya B; Akman S; Süleymanlar G; Colak D
Mikrobiyol Bul; 2013 Jul; 47(3):461-71. PubMed ID: 23971923
[TBL] [Abstract][Full Text] [Related]
7. BK transplant nephropathy successfully treated with cidofovir.
Keller LS; Peh CA; Nolan J; Bannister KM; Clarkson AR; Faull RJ
Nephrol Dial Transplant; 2003 May; 18(5):1013-4. PubMed ID: 12686681
[No Abstract] [Full Text] [Related]
8. Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.
Cabello V; Margarit N; Díaz Pedrero M; Bernal G; Pereira P; Gentil MA
Transplant Proc; 2008 Nov; 40(9):2930-2. PubMed ID: 19010151
[TBL] [Abstract][Full Text] [Related]
9. Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique.
Herman J; Van Ranst M; Snoeck R; Beuselinck K; Lerut E; Van Damme-Lombaerts R
Pediatr Transplant; 2004 Oct; 8(5):485-92. PubMed ID: 15367285
[TBL] [Abstract][Full Text] [Related]
10. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient.
Bjorang O; Tveitan H; Midtvedt K; Broch LU; Scott H; Andresen PA
Nephrol Dial Transplant; 2002 Nov; 17(11):2023-5. PubMed ID: 12401867
[No Abstract] [Full Text] [Related]
11. Currently recommended BK virus (BKV) plasma viral load cutoff of ≥4 log10/mL underestimates the diagnosis of BKV-associated nephropathy: a single transplant center experience.
Hassan S; Mittal C; Amer S; Khalid F; Patel A; Delbusto R; Samuel L; Alangaden G; Ramesh M
Transpl Infect Dis; 2014 Feb; 16(1):55-60. PubMed ID: 24283677
[TBL] [Abstract][Full Text] [Related]
12. [BK virus-associated nephropathy].
Kaltenis P
Medicina (Kaunas); 2003; 39(7):637-9. PubMed ID: 12878816
[TBL] [Abstract][Full Text] [Related]
13. BK virus-associated nephropathy in a kidney transplant recipient successfully treated with cidofovir, the first case in Japan.
Akioka K; Okamoto M; Ushigome H; Nobori S; Kaihara S; Yoshimura N
Int J Urol; 2008 Apr; 15(4):369-71. PubMed ID: 18380832
[TBL] [Abstract][Full Text] [Related]
14. BK nephropathy: what is the role of antiviral therapy?
Fishman JA
Am J Transplant; 2003 Feb; 3(2):99-100. PubMed ID: 12614295
[No Abstract] [Full Text] [Related]
15. Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation.
Lee SS; Ahn JS; Jung SH; Ahn SY; Kim JY; Jang HC; Kang SJ; Jang MO; Yang DH; Kim YK; Lee JJ; Kim HJ
Korean J Intern Med; 2015 Mar; 30(2):212-8. PubMed ID: 25750563
[TBL] [Abstract][Full Text] [Related]
16. Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature.
Lamoth F; Pascual M; Erard V; Venetz JP; Nseir G; Meylan P
Antivir Ther; 2008; 13(8):1001-9. PubMed ID: 19195325
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of cidofovir treatment of polyomavirus nephropathy in kidney transplant recipients.
Hua DK; Howard K; Craig JC; Chapman JR; Wong G
Transplantation; 2012 Jan; 93(2):188-94. PubMed ID: 22186937
[TBL] [Abstract][Full Text] [Related]
18. Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples.
Babel N; Fendt J; Karaivanov S; Bold G; Arnold S; Sefrin A; Lieske E; Hoffzimmer M; Dziubianau M; Bethke N; Meisel C; Grütz G; Reinke P
Transplantation; 2009 Jul; 88(1):89-95. PubMed ID: 19584686
[TBL] [Abstract][Full Text] [Related]
19. Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience.
Kwon HJ; Kang JH; Lee JW; Chung NG; Kim HK; Cho B
Transpl Infect Dis; 2013 Dec; 15(6):569-74. PubMed ID: 24028353
[TBL] [Abstract][Full Text] [Related]
20. The status of BK polyomavirus replication in adult renal transplant recipients in northeastern Poland.
Naumnik B; Kowalewska J; Zalewski G; Charkiewicz R; Myśliwiec M
Transplant Proc; 2011 Oct; 43(8):2976-84. PubMed ID: 21996205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
